{"id":"W3198411056","doi":"10.1093/ecco-jcc/jjab152","title":"Is Also the Patient Ready for Switching from Intravenous to Subcutaneous Biologics?","year":2021,"lang":"en","type":"letter","venue":"Journal of Crohn s and Colitis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Canada; Celltrion","keywords":"Vedolizumab; Medicine; Inflammatory bowel disease; Crohn's disease; Subcutaneous injection; Disease; Intensive care medicine; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002423167,0.0006926153,0.0009642016,0.0005940342,0.002483014,0.002408925,0.001170894,0.02477605,0.005981555],"category_scores_gemma":[0.0251842,0.000585816,0.0009115535,0.0005213584,0.002064413,0.00539304,0.001027947,0.02919933,0.00468272],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002731671,"about_ca_system_score_gemma":0.001954051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003464477,"about_ca_topic_score_gemma":0.003708636,"domain_scores_codex":[0.9971023,0.001200593,0.000334617,0.0003707679,0.0006474647,0.0003442011],"domain_scores_gemma":[0.9936128,0.00321753,0.0005262821,0.0001671087,0.001214798,0.001261435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001177139,0.0001113461,0.002826637,0.0001731658,0.00003126164,0.02178801,0.0005887701,0.00009119775,0.0004106039,0.001838524,0.9534212,0.0186016],"study_design_scores_gemma":[0.0002073851,0.0003825375,0.003255094,0.001135019,0.00007455888,0.0867233,0.002498311,0.001087466,0.0005594351,0.007901871,0.8959551,0.0002198478],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0009202967,0.001659288,0.0001507551,0.9822657,0.01311334,0.00001471195,0.00002442139,0.00002495427,0.001826587],"genre_scores_gemma":[0.009565392,0.002131942,0.000371213,0.9559712,0.02815103,0.00002575254,0.00001963737,0.00002224524,0.003741625],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.02477605,"threshold_uncertainty_score":0.02001035,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03467721961218399,"score_gpt":0.2884944352905215,"score_spread":0.2538172156783375,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}